Yunita Nita
Departemen Farmasi Praktis, Fakultas Farmasi, Universitas Airlangga

Published : 15 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 6 Documents
Search
Journal : JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA

Cost of Illness pada Pasien Diabetes Melitus dengan Diabetic Foot: Systematic Review Alvina Dewi Astuty; Gusti Noorizka Veronika Achmad; Yunita Nita; Lestiono Lestiono
JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA Vol. 7 No. 1SI (2020): Special Issue: Seminar Inovasi Teknologi dan Digitalisasi pada Pelayanan Kefa
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/jfiki.v7i1SI2020.20-30

Abstract

Pendahuluan: Diabetes melitus (DM) merupakan salah satu penyebab kematian akibat penyakit tidak menular terbesar di dunia. Diabetes dapat menyebabkan komplikasi lebih lanjut jika pasien tidak patuh dalam menjalani terapi yang diberikan, salah satunya yaitu diabetic foot. DM dengan diabetic foot membawa kerugian ekonomi yang besar. Tujuan: Penelitian ini bertujuan untuk dapat mengetahui cost of illness pada pasien DM dengan diabetic foot dengan systematic review. Metode: Penelitian ini dilakukan dengan metode systematic review dengan menggunakan PRISMA statement yang dilakukan pada bulan April – Juli 2020. Pencarian artikel dilakukan pada Pubmed, Cochrane, Sciencedirect, Scopus, dan Ebscohost dengan menggunakan PICO hingga pada tanggal 22 Juli 2020 dengan kriteria inklusi yaitu studi terkait cost of illness, subyek penelitian merupakan pasien diabetic foot, dan artikel memuat hasil penelitian berupa cost dari diabetic foot untuk menentukan kata kunci yang akan digunakan. Hasil: Dari hasil tujuh artikel didapatkan bahwa total beban biaya yang dihasilkan yaitu 2341,63 USD/tahun hingga 20977,56 USD/tahun untuk perspektif pasien, 2703,24 USD/tahun hingga 8790,41 USD/tahun dan 8129,96 USD/episode untuk perspektif rumah sakit, serta 2144,21 USD/episode dan 14819,78 USD/tahun untuk perspektif pembayar pihak ketiga. Mayoritas penelitian menggunakan metode pengambilan data retrospektif dan bottom-up, sedangkan untuk perspektif yang paling banyak digunakan adalah perspektif rumah sakit. Biaya yang paling banyak dihitung adalah direct medical cost dengan biaya yang dihabiskan mencapai 51,7% hingga 98,4% dari total keseluruhan biaya. Lalu biaya yang dihabiskan untuk pengobatan untuk pasien DM dengan diabetic foot mencapai dua hingga empat kali lebih besar daripada pasien DM tanpa diabetic foot dengan persentase biaya untuk komplikasi diabetic foot mencapai 55,9% hingga 71,7% dari total biaya yang dikeluarkan. Kesimpulan: Pasien DM dengan diabetic foot menghabiskan lebih banyak sumber daya sehingga meningkatkan biaya pengobatan dibandingkan dengan DM tanpa diabetic foot.
Comparative Analysis of Actual Cost and INA CBG Rate in Diabetic Gangrene Inpatients Diajeng Putri Kinanti; Umi Athiyah; Yunita Nita; Muhammad Noor Diansyah
JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA Vol. 8 No. 3 (2021): JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/jfiki.v8i32021.284-292

Abstract

Background: Diabetic gangrene is a complication of diabetes mellitus that imposes a substantial financial burden on patients and their families as well as the health care system. Objective: To determine the total cost of disease, and the difference between real cost and INA CBG rate for diabetic gangrene inpatients from January - December 2017 at Universitas Airlangga Hospital, Surabaya Methods: The study was conducted retrospectively by using a total sampling method. The perspective used was the hospital perspective. This study's direct medical costs were laboratory, drug and consumable medical device costs, medical equipment rental, radiology examination, red cross, oxygen, service, and room costs. Data analysis was performed using an independent samples t-test. Results: The results showed that 148 patients met the inclusion criteria. The total real cost of diabetic gangrene inpatients at Universitas Airlangga Hospital in 2017 was IDR 1,339,949,381, and the total INA CBG rate for inpatients with diabetic gangrene was IDR 1,365,047,500. The difference was (p = 0.000) between real cost and INA CBG rate. Conclusion: There is a difference between the actual cost and the INA CBG rate for diabetic gangrene inpatients.
Linguistic Validation of Indonesian Version of the Audit of Diabetes-Dependent Quality of Life Questionnaire Putri Amelia Rooswita; Yunita Nita; Elida Zairina; Gesnita Nugraheni; Libriansyah Libriansyah
JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA Vol. 8 No. 3 (2021): JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/jfiki.v8i32021.293-300

Abstract

Background: One of the impacts experienced by diabetes mellitus patients is a decrease in their quality of life. The Audit of Diabetes-Dependent Quality of Life (ADDQoL) is a widely used individualized diabetes-specific quality of life measure. However, there was no version available in the Indonesian language. Objective: This study is aimed to undertake linguistic validation, including a cultural adaptation of the ADDQoL questionnaire into the Indonesian language. Method: The original developer granted permission to use and modify the questionnaire. The international linguistic validation procedure developed by the Mapi Research Institute was used. There were six steps involved: forward translation, reconciliation, back translation, expert panel review by a psychologist and clinician, cognitive debriefing with diabetes patients, and proofreading. Result: Problems that arose during the linguistic validation process were resolved by finding conceptually equivalent alternatives and changing sentence structures to achieve equivalence in language, concept, and culture with the original version of the ADDQoL. The developer's team reviewed and discussed all actions taken. Cognitive debriefing interviews with five respondents showed that the ADDQoL questionnaire was simple to understand. Conclusion: The Indonesian version of the ADDQoL is linguistically and culturally validated. Further studies are needed to confirm the structure and reliability of the Indonesian ADDQoL.
Cost of Illness Study in Thyroid Patients: A Systematic Review Seisye Junita Miru; Libriansyah; Mufarrihah; Yunita Nita
JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA Vol. 10 No. 1 (2023): JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/jfiki.v10i12023.92-102

Abstract

Background: The thyroid has a vital role in growth, neurodevelopment, reproduction, and metabolism. About 300 million people around the world had been reported to be suffering from thyroid disorders, but more than half were unaware. The factors of sex, age, weight of disease, and other accompanying conditions should be considered, otherwise, it will cause a long time treatment period in which the cost will become higher from year to year. Purpose: The systematic review aims to provide an overview of the financial burden caused by thyroid disease for the communities, governments and health care providers. Method: A systematic review of publications in several databases, namely PUBMED, SCIENCE DIRECT, DOAJ, SCOPUS and GOOGLE SCHOLAR. Results: Six research articles were obtained from publications selected for systematic review. The reviewed articles show overviews of the cost of thyroid disease in several countries. The financial burden of thyroid patients in some countries varies, with different perspectives. The lowest to highest cost ranges from 0.125 USD/patient – 8106 USD/patient. Conclusion: The study in this review illustrates the various costs in different countries; the cost of screening, and thyroid surgery has the largest contribution compared to other costs; research on the financial burden suffered by thyroid patients in the future must be carried out continuously and periodically to be able to estimate the cost of therapy more appropriately to provide a useful data for health care providers, governments and the community. Direct medical costs are the largest proportion.
Translation and Cultural Adaptation of Multi-Attribute Utility Instrument (MAUI) Indonesian Version of the 15D Questionnaire Dian Parwati; Libriansyah; Gesnita Nugraheni; Yunita Nita
JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA Vol. 10 No. 2 (2023): JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/jfiki.v10i22023.162-172

Abstract

Background: Diabetes mellitus is a chronic metabolic disorder that cannot be cured and progressively develop into a complication affecting the patient's health-related quality of life (HRQoL). The utility is a measure of preference-based HRQoL. Indirect utility measurements can be measured using the Multi-Attribute Utility Instrument (MAUI) instrument, one of which is the 15D questionnaire that has never been translated and adapted culturally in Indonesian. Objective: Translating and culturally adapting the 15D questionnaire to Indonesian diabetes mellitus patients. Methods: The translation process was carried out through the stages of forward translation, reconciliation, and backward translation involving two qualified translators and three experts in their field. The pilot test stage involved eight respondents consisting of 6 diabetes mellitus patients and two healthy individuals. Results: Problems in the linguistic validation process led to more conformity of word equivalents from the original to the target language. The agreement found was in the area of semantic equivalence, idiomatic equivalence, and experiential equivalence. The problem was resolved by reconciliation during the Focus Group Discussion, which translators and experts in their field attended and discussed with the original author to get equality of meaning in terms of language and culture. The Indonesian version of the 15D questionnaire tested on eight respondents showed results that were easy to understand and straightforward. Conclusion: The Indonesian version of the 15D questionnaire is valid from the linguistic and cultural adaptation stage. Further research is needed relating to the validation and reliability of the questionnaire.
Comparative Analysis of Real Costs and INA CBG's Rates in BPJS Kesehatan Patients with Schizophrenia Oktarina Mahanggi; Abdul Rahem; Yunita Nita
JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA Vol. 10 No. 2 (2023): JURNAL FARMASI DAN ILMU KEFARMASIAN INDONESIA
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/jfiki.v10i22023.217-223

Abstract

Background: Schizophrenia is the most severe mental disorder because its risk of death is to 2-3 times higher. Objective: To determine the average real costs, the difference between real costs and INA-CBG rates of inpatients with schizophrenia, and the factors that affect real costs. Methods: The study was conducted retrospectively from the hospital perspective using the total sampling method from January 2020-December to 2021. The study sample included inpatients patients and the real costs of the hospital. The data obtained were analyzed using the Mann-Whitney U-test and multiple linear regression tests. Results: About 112 patients met the inclusion criteria. The average real cost of inpatients with schizophrenia at Tombulilato General Hospital from January 2020 to December 2021 is Rp. 9,895,102 and the average INA-CBG rate of inpatients with schizophrenia was Rp. 14,820,778. There was a difference between the real costs and INA-CBG rates (p = 0.002), with the highest average hospital real cost component in the inpatient room (Rp. 3,397,723 (34.34%). The factor that affected the real costs of inpatients with schizophrenia patients is the length of stay (p = 0.000). Conclusion: The real costs of the hospital were lower (p = 0.002) than those of the INA-CBG. The highest real cost of the hospital was the inpatient room (34.34%), and the factor that affected the real costs was the length of stay (p = 0.000).
Co-Authors A. A. Rai Mas Feby Kumala Dewi Aanisah Nabiilah Abby Rahmat Kamaruzzaman Abdul Rahem Aina Senja Yuliyani Aisyia Aisyia Ajeng Ambar Sari Alfira Maulidyah Rahmah Alisa Sari Nastiti Alvina Dewi Astuty Alysa Intan Santika Amelia Ghaisani Ana Yuda Andi Hermansyah Andika Fajar Fortuna Dhonny Kusuma Andreas Bayu Eka Wijayanto Andwynanda Bhadra Nareswari Andyko Ismareka Putra Angeline Tirza Galuh Palupi Anisa Maulidi Syavira Anisah Febrian Rahmawati Anita Nur Azizah Annisa Febriani Putri Arie Sulistyarini Athaya Bella Azzahrya Ayu Larasati Azza Maulidia El Java Azzalin Devariany Mufidah Bella Rizkia Dianita Cordellia Calista Amelia Devinta Julian Tupenalay Dewi Fatima Auzianingrum Muntari Diah Ayu Wakita Trimanda Diajeng Putri Kinanti Dian Parwati Dwi Rekno Ningrum Dyandra Anjani Putri Elida Zairina Elsa Ananda Setya Budi Farhan Athallah Rafif Febria Tri Erliana Firman Wahyudi Friesca Surya Nurhaidah Gesnita Nugraheni Gusti Noorrizka Veronika Ahmad Hana Sofiana Maghfira Helmy Kurniawan Ira Puspitasari Jamhari Jamhari Jessica Febe Prawadi Kambarwati Nur Shofa Khintan Rizky Fadhila Lestiono Lestiono Lestiono Lestiono Libriansyah Libriansyah Libriansyah Lichijati Lichijati Luthfia Hany Primadani Mochammad Haris Firdaus Mufarrihah, Mufarrihah Muhammad Noor Diansyah Muhammad Thariq Nadhafi Muhammad Zaesal Rizki Muzaffar Musdar, Tamzil Azizi Nada Aprilliya Nadhira Mileni Tsalitsia Neva Safitri Salsabila Ni Putu Widya Sriastuti Noer Aqiel Natsier Nursanti Arya Pratiwi Oktarina Mahanggi Putri Amelia Rooswita Rahmadi Wahyu Bowolaksono Ridka Aulia Santi Rini Ayu Agustin Rizdamaya Lintang Herfadanti Rossika Rachmafebri Salsabila Khairunnisa Salsabilla Madudari Kasatu Seisye Junita Miru Shafira Dwita Anugrah Sinta Wahyu Nur Muthi Siti Sarah Sylvia Annisa Mahardiani Tasya Mahira Salsabila Theresia Florida Damayanti Tri Wahyudi Umi Athiyah Via Qurrota A’yun Vidya Annisa Pebriastika Virnanda Syafira Hartatiningrum Wahyuri Wahyuri Wikanti Sunaringtyas Wiwin Dwi Rahmadani Tukloy Yuniar Gusrianti Azzahra